Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Genmab soars to record highs after cancer drug succeeds in key trial

The drugmaker’s market value swelled by more than $7 billion on findings suggesting a recently-acquired medicine could become a new treatment standard for a form of head and neck cancer.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Thursday 29 October →